Previous Article | Next Article ![]()
Journal of Bacteriology, March 2007, p. 2487-2496, Vol. 189, No. 6
0021-9193/07/$08.00+0 doi:10.1128/JB.01491-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

,1,2
Katarzyna Schiwon,1
Michal Burzynski,1,
Mike Döring,1
Christine Bohn,1 and
Elisabeth Grohmann1*
Department of Environmental Microbiology/Genetics, University of Technology, D-10587 Berlin, Germany,1 Institute for Chemistry, Karl-Franzens-Universität Graz, A-8010 Graz, Austria2
Received 21 September 2006/ Accepted 24 December 2006
|
|
|---|
, M. Mägdefrau, K. Andreas, W. Keller, C. Bohn, M. Y. Abajy, and E. Grohmann, Microbiology 152:637-645, 2006). The pIP501 tra operon is negatively autoregulated at the transcriptional level by the conjugative DNA relaxase TraA. Three of the 15 pIP501-encoded Tra proteins show significant sequence similarity to the Agrobacterium type IV secretion system proteins VirB1, VirB4, and VirD4. Here we report a comprehensive protein-protein interaction map of all of the pIP501-encoded Tra proteins determined by the yeast two-hybrid assay. Most of the interactions were verified in vitro by isolation of the protein complexes with pull-down assays. In conjunction with known or postulated functions of the pIP501-encoded Tra proteins and computer-assisted prediction of their cellular location, we propose a model for the first type IV-secretion-like system encoded by a conjugative plasmid from gram-positive bacteria. |
|
|---|
Three of the 15 tra gene products show significant similarity with type IV secretion system (T4SS) components required for conjugative DNA transport, DNA transformation, and transfer of effector proteins from G bacteria to eukaryotic hosts (for recent reviews, see references 14, 15, 34, and 46). Orf5pIP501 is a putative VirB4-like ATPase, Orf7pIP501 is a VirB1-type lytic transglycosylase, and Orf10pIP501 is a putative VirD4-like coupling protein (Fig. 1). These proteins are also conserved in the pIP501-related plasmids pRE25 from E. faecalis, pSK41/pGO1 from Staphylococcus aureus, and pMRC01 from Lactococcus lactis (in pMRC01, the Orf7 ortholog is missing). Details on the modular structure of the tra regions of these plasmids and their similarities have been summarized by Grohmann et al. (26). The Orf7pIP501 protein has been shown to efficiently cleave peptidoglycan isolated from E. faecalis as well as from E. coli (C. Söllü and E. Grohmann, unpublished data). Functional characterization of the two putative ATPases/ATP binding proteins is in progress.
![]() View larger version (20K): [in a new window] |
FIG. 1. Organization of the pIP501 tra region. The overlapping oriT and Ptra regions are indicated (not to scale). The operon (orf1 to orf15) is terminated by a putative strong rho-independent termination signal (hairpin). Hatched segments indicate genes encoding proteins similar to those identified in G bacterial T4SSs. The Orf5 protein shows conserved features, a nucleotide binding site motif A (Walker A box 250GLSGGGKT257) and a motif B (Walker B box 509DEFHFLL515), of proteins belonging to the VirB4 family of nucleoside triphosphate-binding proteins (COG3451). Orf10 is a member of the pfam02534 family of TraG/TrwB/TraD/VirD4 coupling proteins. It shows the P-loop motif (Walker A box) and a Walker B motif for nucleotide binding. Orf7 (a VirB1 homolog of the Agrobacterium T-DNA transfer system) contains the SLT domain present in bacterial lytic transglycosylases and was shown to cleave peptidoglycan isolated from E. faecalis and E. coli in an in vitro muramidase assay (Söllü and Grohmann, unpublished data). Open reading frames whose corresponding gene products contain potential signal peptide sequences are marked with a black wedge within the segment.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial and yeast strains used in this work
|
|
View this table: [in a new window] |
TABLE 2. Plasmids used in this work
|
Cloning of tra genes for protein-protein interactions. (i) Yeast two-hybrid assay. The pIP501 tra genes were amplified by PCR using the primers listed in Table 3. They were inserted as SalI/NotI DNA fragments into SalI/NotI-cut pBTM117c and pGAD426 plasmids. The nucleotide sequences of the insertions were verified by dideoxy chain termination sequencing in an automated sequencer (ABI prism 310; Perkin Elmer, Rodgau, Jügesheim, Germany) performed by Services in Molecular Biology (Berlin, Germany).
|
View this table: [in a new window] |
TABLE 3. Oligonucleotides used in this work
|
Yeast two-hybrid assay. A general description of the two-hybrid system has been detailed elsewhere (21). Before being used in the two-hybrid assay, all 15 pBTM117c-tra plasmids were transformed into the yeast L40ccU strain (a kind gift of E. Wanker, MDC Berlin, Germany), and the resulting transformants were tested for the absence of autoactivation of the lacZ and HIS3 reporter genes. In order to test for protein-protein interaction, the pBTM117c and pGAD426 plasmids carrying the respective tra genes were cotransformed into the yeast L40ccU strain and plated on SD minimal medium lacking leucine and tryptophan. After incubation at 30°C for 2 to 3 days, the transformants were replica plated on SD medium lacking leucine, tryptophan, and histidine and with galactose and raffinose as sugar sources (SD-leu-tryp-his/gal/raff medium) and incubated at 30°C for 3 to 10 days for selection of interacting proteins. From the SD-leu-tryp-his/gal/raff plates, replica filters were made and cells were permeabilized by freezing in liquid nitrogen (10 s) and thawing at room temperature. Filters were transferred onto Whatman 3MM paper saturated with X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside acid) solution (10) and incubated at 37°C. ß-Galactosidase-positive clones were tested further by a quantitative ß-galactosidase assay with CPRG (chlorophenol red-ß-D-galactopyranoside) as the substrate. A single colony from the SD-leu-tryp-his/gal/raff plate was inoculated into 5 ml SD-leu-tryp-his/gal/raff medium and grown overnight at 30°C. A 1-ml aliquot of this preculture was used to inoculate 5 ml of fresh SD-leu-tryp-his/gal/raff medium. The cells were grown to an A600 of 0.5 to 0.8; the exact A600 was recorded. A 1.5-ml aliquot of this culture was centrifuged at 14,000 x g for 30 s to harvest the cells. The cells were resuspended in 0.3 ml of buffer 1 (HEPES, 2.38%; NaCl, 0.9%; L-aspartate, 0.065%; bovine serum albumin, 1%; Tween 20, 0.05% [pH 7.3]; with a concentration factor of 5). A 0.1-ml aliquot of the cells was permeabilized by two freeze/thaw cycles in liquid nitrogen and a 37°C water bath. A solution of 0.7 ml of buffer 2 (2.23 mM CPRG in buffer 1) was added and vigorously mixed. Cells were incubated at 37°C until the samples developed a red color. To stop color development, 3 mM ZnCl2 (0.5 ml) was added. Samples were centrifuged at 14,000 x g for 1 min to pellet cell debris. The A578 was measured, and the number of ß-galactosidase units was calculated with the following formula: ß-galactosidase units = 1,000 x [A578/(t x V x A600)] (36, 37), where t is the elapsed time (in min) of incubation, V is 0.1x concentration factor (5), and A600 is the value for 1 ml of sample.
Expression of fusion proteins.
E. coli XL10 or BL21-CodonPlus(DE3)-RIL harboring the recombinant expression plasmids was inoculated into 10 ml of LB broth containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol and grown overnight at 37°C. The preculture was used to inoculate 200 ml of fresh LB broth containing the same antibiotics. The cells were grown at 37°C to A600s of 0.3 (7xHis-Orf8, 22.4 kDa), 0.6 (MBP-Orf7
TMH, 78.5 kDa; 6xHis-Orf1, 78.6 kDa; 6xHis-Orf1N246, 31.6 kDa; and 7xHis-Orf15, 33.6 kDa), 0.8 (MBP-Orf4, 65.5 kDa; 7xHis-Orf10, 66.2 kDa; 7xHis-Orf12, 36.1 kDa; and GST-Orf14, 42.2 kDa), or 1.0 (MBP-Orf5, 119.2 kDa; MBP-Orf10, 106.4 kDa; 7xHis-Orf5, 77.8 kDa; and 7xHis-Orf7, 44.1 kDa) and induced by the addition of isopropyl-ß-D-thiogalactopyranoside (IPTG). Gene expression was induced overnight, with the exception of Orf7 fusions, which were induced only for 3 h due to the cell toxicity of the protein. MBP-Orf7
TMH expression was induced by the addition of IPTG to a concentration of 0.5 mM. Protein synthesis of all other proteins was induced with 1 mM IPTG. The solubility of each protein or protein fragment was assessed by harvesting the cells, resuspending them in 10 ml of lysis buffer [100 mM K2HPO4/KH2PO4, 50 mM (NH4)2SO4, 1% Triton X-100 (pH 7)], lysing them by the addition of lysozyme (1 mg/ml), and administering ultrasonic treatment. The cell debris was pelleted by centrifugation, and the supernatant was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie blue staining. Partial solubility of 7xHis-Orf10 was achieved by the following procedure: the cell pellet was resuspended in 20 mM Tris-HCl, 300 mM NaCl, 1 mM EDTA (pH 7.5). Lysozyme was added to a final concentration of 1 mg/ml, and the samples were incubated on ice for 20 min and centrifuged at 16,000 x g at 4°C for 20 min. The pellet was washed twice with 50 mM EDTA (pH 8.0) and centrifuged at 16,000 x g at 4°C for 10 min. The pellet was partially dissolved in buffer A (8 M urea, 20 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole [pH 7.5]) and centrifuged at 30,000 x g at 4°C for 30 min. The supernatant was loaded onto a Ni2+ charged HiTrap chelating column (Amersham Biosciences, Freiburg, Germany) equilibrated with buffer A. The 7xHis-Orf10 protein was eluted in a 10-column-volume gradient with buffer B (8 M urea, 20 mM Tris-HCl, 500 mM NaCl, 250 mM imidazole [pH 7.5]) and concentrated in a Centricon centrifugal filter unit (Millipore, Schwalbach, Germany) with a 30-kDa cutoff. The concentrated protein solution was loaded onto a HiTrap desalting column (Amersham Biosciences, Freiburg, Germany) equilibrated with 30 mM Tris-HCl, 300 mM NaCl, 20 mM MgCl2 (pH 7.5). To assess the integrity and purity of the 7xHis-Orf10 protein, an aliquot of the purified protein was loaded onto a 10% SDS polyacrylamide gel, followed by Coomassie blue staining. 7xHis-Orf10 was purified to approximately 80% homogeneity (J. Kope
and E. Grohmann, unpublished data).
In vitro binding experiments. E. coli BL21-CodonPlus(DE3)-RIL lysate or E. coli XL10 lysate with the expression plasmid (pMAL-c2X, pQTEV/pQE30, or pGEX-6P-2) containing the inserted traX gene was mixed with the putative interaction partner (E. coli lysate with pQTEV-/pQE30-, pGEX-6P-2-, or pMAL-c2X-traY or partially purified TraY protein) and incubated for complex formation for 30 to 60 min at room temperature. The complex was loaded onto amylose magnetic beads (New England Biolabs, Frankfurt am Main, Germany) and purified as specified by the manufacturer. Alternatively, the mixture of two E. coli lysates was loaded onto Ni-nitrilotriacetic acid (NTA) spin columns (QIAGEN, Hilden, Germany), and the protein complex was eluted as specified by the manufacturer, mixed with SDS sample buffer, and after heat denaturation, loaded onto SDS-polyacrylamide gels with the appropriate percentage of acrylamide (6 to 12%). Two gels were made per complex: one was stained with Coomassie brilliant blue (Merck, Darmstadt, Germany), and the other was used for Western blotting. The separated proteins were blotted onto nitrocellulose membranes (Bio-Rad, München, Germany) using liquid transfer for 1.5 h at 90 mA (Mini ProteanIII system; Bio-Rad, München, Germany). The membranes containing the transferred proteins were initially incubated in the blocking solution (QIAGEN, Hilden, Germany). The seven-histidine-tag fusion protein (six-histidine-tag fusion protein for Orf1) was detected by incubating the membrane with 5 ml of five-histidine horseradish peroxidase (HRP) conjugate (QIAGEN; dilution, 1:5,000), the MBP fusion protein was detected by incubation with 5 ml of anti-MBP HRP conjugate (New England Biolabs; dilution, 1:5,000), and the GST fusion protein was detected by incubation with 5 ml of anti-GST HRP conjugate (Roche Diagnostics; 1:5,000 dilution) for 1 h at room temperature. The signal was visualized by using the ECL Western blot detection kit (Pierce, Perbio Science, Bonn, Germany) followed by autoradiography.
Cross-linking experiment with 7xHis-Orf10.
Cross-linking of 7xHis-Orf10 was performed as described by Kope
et al. (30) with minor modifications. The reaction volume of 50 µl consisted of 0.5 mg/ml protein, 100 mM Bicine (pH 7.5), 300 mM NaCl, 1 mM dithiothreitol, and various concentrations of glutaraldehyde (0.002%, 0.003%, 0.004%, 0.005%, 0.006%, 0.007%, 0.008%, and 0.01% [vol/vol]). The reaction was stopped after 15 min by the addition of 1 M glycine (pH 8.0), to a final concentration of 140 mM. The samples were incubated for another 5 min. The proteins were precipitated with 400 µl of cold acetone for 2 h at 20°C and centrifuged at 15,000 x g for 15 min at room temperature. Prior to being loaded onto a 10% (wt/vol) polyacrylamide gel in the presence of SDS, the pellets were dissolved in loading buffer consisting of 50 mM Tris-HCl (pH 6.8), 2 mM EDTA, 2% (wt/vol) SDS, 0.1% (wt/vol) bromophenol blue, 10% (vol/vol) glycerol, and 150 mM ß-mercaptoethanol and heated to 95°C for 5 min. The samples were electrophoresed at a constant voltage of 180 V and stained with Coomassie brilliant blue.
|
|
|---|
|
View this table: [in a new window] |
TABLE 4. pIP501 Tra protein-protein interactions detected by the yeast two-hybrid system
|
The putative ATPase Orf5 interacts with itself and with Orf4, Orf7, and Orf14. The VirB4-like putative ATPase Orf5 (653 amino acids) was shown to strongly interact with itself (111.8 ß-galactosidase units) (Table 4). It also interacts with two non-T4SLS proteins, Orf4 and Orf14, which are predicted to be located at least partially in the cytoplasm. Orf5 also bound to the lytic transglycosylase Orf7. This interaction could possibly help recruit the putative energizing protein Orf5 to its location in the transfer complex.
The lytic transglycosylase Orf7 interacts with itself and with Orf2, Orf5, Orf10, and Orf14. Orf7 (369 amino acids) demonstrated five different interactions with pIP501-encoded Tra proteins. The protein was shown to interact with all T4SLS proteins encoded by the pIP501 tra operon. It bound to the putative ATPase Orf5, formed homodimers, and bound to the putative coupling protein Orf10. Orf7 self-interaction is in agreement with dimerization of the lytic transglycosylase VirB1 of the Agrobacterium transfer DNA (T-DNA) transfer system shown by Ward et al. (53). Putative intermediate complex formation between Orf7 and Orf10 could aid in transporting the coupling protein to its location in the T4SLS complex. The Orf7-Orf10 interaction is an interaction specific for G+ bacteria which has not shown before for any of the T4SSs from G bacteria. Orf7 also bound to the predicted cytoplasmic membrane protein Orf2 and to the Orf14 protein.
The putative coupling Orf10 binds to Orf1, Orf6, and Orf7. Orf10 was excluded as a bait from the screen, as it showed autoactivation when orf10 was cloned into the bait plasmid pBTM117-c. But when Orf1, Orf6, or Orf7 was used as a bait, Orf10 associated with these proteins, showing a very strong interaction with the Orf6 protein (95.3 ß-galactosidase units) (Table 4). The proposed interaction with the TraA relaxase Orf1 was not convincingly shown by the genetic screen (Table 4) and therefore had to be verified by the in vitro pull-down assay (see below) (Table 4).
Protein-protein interactions of non-T4SLS proteins. Most interactions were shown for the Orf14 protein, five interactions in total, including those with the T4SLS proteins Orf5 and Orf7. Orf14 proved to self-associate and to bind to the putative membrane-associated Orf8 protein and the cytoplasmic membrane protein Orf12 (six or seven predicted transmembrane helices [TMH]). Orf6 bound weakly to the Orf3 protein (one or two predicted TMH). The predicted cytoplasmic membrane protein Orf9 (two TMH) interacted strongly with the Orf3 protein. Orf15 is postulated to be located in the cell wall associated with the cytoplasmic membrane protein Orf12. This interaction could enable formation of the outermost part of the DNA/protein secretion machinery.
Most of the in vivo-detected protein-protein interactions were verified by in vitro pull-down assays with differently (six-histidine-/seven-histidine-, GST-, or MBP-) tagged Tra proteins. All in vitro protein-protein interaction data are summarized in Fig. 2 and Table 4.
![]() ![]() View larger version (115K): [in a new window] |
FIG. 2. In vitro binding assays. (A to E) SDS-PAGE gels (left panels) and corresponding Western blots (right panels). (A) Interactions probably involved in recruitment of Tra proteins to the T4SLS complex. (A1) 12% SDS-PAGE. Lane 1, low-range protein standard (Bio-Rad); lane 2, GST-Orf14 lysate; lane 3, 7xHis-Orf7 lysate; lane 4, negative control 7xHis-Orf7/GST; lane 5, eluate of the GST-Orf14-7xHis-Orf7 complex. Corresponding Western blot with anti-GST antibodies. (A2) 6% SDS-PAGE. Lane 1, low-range protein standard; lane 2, MBP-Orf7 TMH lysate; lane 3, 7xHis-Orf5 lysate; lane 4, negative control 7xHis-Orf5/MBP; lane 5, eluate of the 7xHis-Orf5-MBP-Orf7 TMH complex. Corresponding Western blot with anti-MBP antibodies. (A3) 8% SDS-PAGE. Lane 1, low-range protein standard; lane 2, 7xHis-Orf10; lane 3, MBP-Orf7 TMH lysate; lane 4, negative control MBP-Orf7 TMH/pQTEV lysate; lane 5, eluate of the MBP-Orf7 TMH-7xHis-Orf10 complex. Corresponding Western blot with anti-Penta-His antibodies.(B) Interactions of postulated core complex components. (B1) 12% SDS-PAGE. Lane 1, low-range protein standard; lane 2, 7xHis-Orf8 lysate; lane 3, GST-Orf14 lysate; lane 4, proteins not bound to Ni-NTA column; lanes 5 and 6, wash steps after binding of the protein complex; lane 7, eluate of the 7xHis-Orf8-GST-Orf14 complex. Corresponding Western blot with anti-GST antibodies. (B2) 12% SDS-PAGE. Lane 1, low-range protein standard; lane 2, 7xHis-Orf12 lysate; lane 3, GST-Orf14 lysate; lane 4, negative control 7xHis-Orf12/GST; lane 5, eluate of the 7xHis-Orf12-GST-ORF14 complex. Corresponding Western blot with anti-GST antibodies. (C) Interactions of the putative coupling protein Orf10 in a 12% SDS-PAGE gel. Lane 1, low-range protein standard; lane 2, 6xHis-Orf1N246; lane 3, negative control MBP/6xHis-Orf1N246; lane 4, eluate of the MBP-Orf10-6xHis-Orf1N246 complex; lane 5, eluate of the MBP-Orf10-6xHis-Orf1 complex. Corresponding Western blot with anti-Penta-His antibodies. (D) Interactions of the putative ATPase ORF5. (D1) 12% SDS-PAGE. Lane 1, low-range protein standard; lane 2, MBP-Orf5 lysate; lane 3, 7xHis-Orf5 lysate; lane 4, negative control 7xHis-Orf5/MBP; lane 5, eluate of the 7xHis-ORF5-MBP-ORF5 complex. Corresponding Western blot with anti-MBP antibodies. (D2) 12% SDS-PAGE. Lane 1, low-range protein standard; lane 2, GST-Orf14 lysate; lane 3, 7xHis-Orf5 lysate; lane 4, negative control 7xHis-Orf5/GST; lane 5, eluate of the 7xHis-Orf5-GST-Orf14 complex. Corresponding Western blot with anti-GST antibodies. (D3) 10% SDS-PAGE. Lane 1, low-range protein standard; lane 2, MBP-Orf4 lysate; lane 3, 7xHis-Orf5 lysate; lane 4, negative control 7xHis-Orf5/MBP; lane 5, eluate of the 7xHis-Orf5-MBP-Orf4 complex. Corresponding Western blot with anti-MBP antibodies. (E) Homotypic interaction of the lytic transglycosylase Orf7 in a 12% SDS-PAGE. Lane 1, low-range protein standard; lane 2, 7xHis-Orf7 lysate; lane 3, purified MBP-Orf7 TMH; lane 4, proteins not bound to Ni-NTA column; lane 5, wash step after binding of the protein complex; lane 6, eluate of the 7xHis-Orf7-MBP-Orf7 TMH complex. Corresponding Western blot with anti-MBP antibodies.
|
TMH complex. Binding of MBP-Orf7
TMH to the putative coupling protein Orf10 was confirmed by pulling down a complex consisting of MBP-Orf7
TMH and 7xHis-Orf10 from the amylose magnetic beads. Interactions of postulated core complex components. Association of Orf8 with Orf14, thought to constitute an important part of the translocation complex in the cytoplasmic membrane, was confirmed by complex formation between 7xHis-Orf8 and GST-Orf14 (Fig. 2B). Interaction of the cytoplasmic membrane protein Orf12 (six or seven predicted TMH) with Orf14 has been shown by isolation of a 7xHis-Orf12-GST-Orf14 complex.
Interactions of the putative coupling protein Orf10. The weak interaction in the yeast system between the Orf1 (TraA relaxase) and the Orf10 coupling protein was proven in vitro by complex formation between 6xHis-Orf1 and MBP-Orf10 (Fig. 2C). This interaction is a further hint for the putative coupling role of Orf10. Orf10 is thought to link the relaxosome consisting of Orf1 bound to single-stranded pIP501 DNA with the T4SLS complex. 6xHis-Orf1N246, containing the 246 amino-terminal amino acids of the relaxase (the relaxase domain), did not support complex formation with MBP-Orf10. The postulated Orf10 self-association was convincingly confirmed by glutaraldehyde cross-linking. At glutaraldehyde concentrations between 0.002% and 0.005%, predominantly dimeric 7xHis-Orf10 forms appeared in the 10% SDS polyacrylamide gel, whereas at a glutaraldehyde concentration of 0.01%, only multimeric forms were detectable (Fig. 3). Preliminary gel filtration experiments with purified 7xHis-Orf10 confirmed the oligomeric structure of Orf10 (M. Saleh, W. Keller, and E. Grohmann, unpublished data). With the yeast two-hybrid system, Orf10 dimerization could not be tested due to autoactivation of Orf10 in fusion with the BD domain of pBTM117c. Orf10 also interacted with the lytic transglycosylase Orf7 (see above).
![]() View larger version (34K): [in a new window] |
FIG. 3. Glutaraldehyde cross-linking of 7xHis-Orf10. Samples of 0.5 mg/ml of 7xHis-Orf10 were incubated with increasing glutaraldehyde concentrations. The products were loaded onto a 10% SDS polyacrylamide gel, electrophoresed at a constant voltage of 180 V, and stained with Coomassie brilliant blue. Lane 1, SeeBlue plus2-prestained protein standards (Invitrogen, Karlsruhe, Germany); lane 2, no glutaraldehyde; lanes 3 to 10, glutaraldehyde at 0.002% (lane 3). 0.003% (lane 4), 0.004% (lane 5), 0.005% (lane 6), 0.006% (lane 7), 0.007% (lane 8), 0.008% (lane 9); and 0.01% (lane 10).
|
Homotypic interaction of the lytic transglycosylase Orf7 (Fig. 2E).
ORF7 could be isolated as a 7xHis-Orf7-MBP-Orf7
TMH complex from a Ni affinity column. Orf7 could fulfill a bifunctional role in the T4SLS process: its amino-terminal specific lytic transglycosylase (SLT) domain was shown to efficiently cleave peptidoglycan (Söllü and Grohmann, unpublished data), and its carboxy-terminal portion is postulated to be released as an immunoreactive Orf7* protein. The Orf7 amino acid sequence shows significant similarity with VirB1 in the region where VirB1 is processed to VirB1* (4), which leads us to the speculation that, similarly, Orf7 could be processed to VirB1. One possible role of the processed protein could be participation in direct interactions with the recipient cell.
|
|
|---|
![]() View larger version (51K): [in a new window] |
FIG. 4. Working model for pIP501 conjugative transfer. The postulated DNA secretion complex is assembled in a manner reminiscent of a simplified T4SS. Arrows indicate protein-protein interactions determined with the yeast two-hybrid system. Protein localization is consistent with computer predictions made by using Psort (22), PHDhtm (42), HMMTOP (50, 51), TMPred (28), TMAP (39, 40), and TopPred (16, 52) (available at www.expasy.org). Decreased shading of peptidoglycan (PG) symbolizes Orf7-mediated local opening of PG. (a) Protein-protein interactions detected for Orf7. (b) Assembly of the putative pIP501 transport apparatus. Numbers refer to proteins specified by the pIP501 tra region. Dashed arrows mark putative ATPases. CM, cytoplasmic membrane; ssDNA, single-stranded DNA; NTP, nucleoside triphosphate; NDP, nucleoside diphosphate.
|
, W. Keller, and E. Grohmann, unpublished data).
One possible candidate for delivering energy by ATP hydrolysis for establishment of the DNA transfer machinery and for the transport process would be the VirB4-like Orf5 protein. Alternatively, energy could be supplied by the putative coupling protein Orf10. ATP-binding and hydrolysis tests are in progress for both proteins to investigate this assumption. Preliminary experiments showed ATP-binding and ATPase activities for both Orf5 and Orf10 (R. Salih, M. Saleh, M. Abajy, J. Kope
, and E. Grohmann, unpublished results). A possible transenvelope structure could be built up by the Orf8, Orf14, Orf12, and Orf15 proteins. Orf8 and Orf15 contain potential signal peptides at their N termini; for Orf8, a TMH in the N-terminal portion was postulated. Depending on the algorithm applied, for ORF15, one or two TMH were found (one at the amino terminus and another one at the carboxy terminus). The PSORTb v.2.0 program (22) suggested cell wall localization for the Orf15 protein. Therefore, Orf15 could possibly make up the outermost portion of the transport complex. For Orf12, five to seven TMH have been postulated. Orf12 and Orf14 were analyzed with the Secretome 2.0 prediction tool (7) (www.cbs.dtu.dk/services/SecretomeP-2.0/), which predicts nonclassically secreted proteins (proteins without a signal peptide). For both proteins, a high SecP score for nonclassically secreted proteins was obtained (threshold, 0.5), namely, 0.94 for Orf12 and 0.84 for Orf14.
The proteins Orf3, Orf6, and Orf9, which all possibly contain TMH, could build part of the scaffold structure of the secretion apparatus. Orf9 also contains a possible signal peptide sequence with a high probability of cleavage (0.92). Orf6 showed strong interaction (95.3 ß-galactosidase units) with the putative coupling protein Orf10. For two proteins with postulated TMH, Orf11 and Orf13, no interactions could be detected so far. Both proteins show no significant similarity to any characterized protein in the data bank. The soluble protein Orf4, with no significant match in the data bank, showed high affinity (91.2 ß-galactosidase units, Table 4) for the Orf5 protein in the yeast two-hybrid screen. A possible physiological significance of this association has to be further investigated.
Comparisons of the plasmid-encoded conjugative transfer systems in G+ bacteria revealed two general mechanisms governing conjugative plasmid transfer, namely (i) a T4SLS mechanism such as that proposed for the broad-host-range plasmids pIP501, pRE25, pMRC01, and pSK41/pGO1 (26, 33, 34); the Clostridium perfringens plasmid pCW3 (3); and the E. faecalis sex pheromone plasmids as exemplified by pCF10 (31); and (ii) a completely distinct mechanism exerted by the multicellular G+ bacteria (26, 41).
In G+ bacteria, the close contact between donor and recipient cells preceding conjugative transfer is thought to be established without the help of pili. With the exception of the Enterococcus sex pheromone plasmids, the mechanism of establishing physical contact between G+ donor and recipient cells is not known (reviewed in references 11 and 19). Interestingly, last year, pili were characterized in all three of the principal streptococcal pathogens that cause invasive disease in humans, Streptococcus pyogenes, S. agalactiae, and S. pneumonia (reviewed in reference 48). In G bacteria, pili are typically formed by noncovalent interactions between pilin subunits. By contrast, the recently discovered pili in G+ pathogens are formed by covalent polymerization of adhesive pilin subunits. Pili of G+ pathogens are likely to have a function similar to that in G bacteria, where they play a key role in the adhesion and invasion process and in pathogenesis. In G bacteria, only type IV pili were shown to allow the transfer of genetic material (12). Type IV pilin-like proteins have also been demonstrated to be involved in genetic transformation of G+ bacteria (reviewed in reference 2). Although no pilin-like genes have been found on conjugative plasmids with a G+ bacterial origin, participation of pilus-like structures in the conjugative transfer process of G+ bacteria cannot be excluded to date.
In summary, we have presented a first model for a T4SL transfer system encoded by the broad-host-range plasmid pIP501 with self-transmission capability to a wide variety of G+ bacteria and to G E. coli. The further elucidation of the pIP501 conjugative transfer mechanism should also aid in deciphering the transfer process of the related staphylococcal and enterococcal antibiotic resistance plasmids, enabling the development of specific agents inhibiting T4SLS processes in G+ pathogens.
M.Y.A. is a recipient of a doctoral fellowship from the University of Aleppo, Syria. J.K. received a scholarship from Berliner Programm zur Förderung der Chancengleichheit für Frauen in Forschung und Lehre. This work was partially supported by the Austrian Science Foundation (FWF project P15040).
Published ahead of print on 5 January 2007. ![]()
Present address: Department of Biochemistry and Molecular Biology, University of Medical Sciences, Pozna
, Poland. ![]()
|
|
|---|
, J., A. Bergmann, G. Fritz, E. Grohmann, and W. Keller. 2005. TraA and its N-terminal relaxase domain of the Gram-positive plasmid pIP501 show specific oriT binding and behave as dimers in solution. Biochem. J. 387:401-409.[CrossRef][Medline]
, M. Mägdefrau, K. Andreas, W. Keller, C. Bohn, M. Y. Abajy, and E. Grohmann. 2006. The TraA relaxase autoregulates the putative type IV secretion-like system encoded by the broad-host-range Streptococcus agalactiae plasmid pIP501. Microbiology 152:637-645.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»